Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantRecurrenceCombined Modality TherapyAntineoplastic AgentsTreatment OutcomeCisplatinCyclophosphamideDoxorubicinDisease-Free SurvivalPrognosisSurvival AnalysisNeoadjuvant TherapyEtoposideBreast NeoplasmsNeoplasm StagingSurvival RateNeoplasm Recurrence, LocalTime FactorsDrug Administration ScheduleMethotrexateLung NeoplasmsPhotic StimulationFollow-Up StudiesCarboplatinVinblastineSalvage TherapyPaclitaxelInduction ChemotherapyDrug Resistance, NeoplasmPrecursor Cell Lymphoblastic Leukemia-LymphomaCytarabineBleomycinTaxoidsTransplantation, AutologousIfosfamideAntimetabolites, AntineoplasticNeoplasmsTesticular NeoplasmsHodgkin DiseaseDeoxycytidineHematopoietic Stem Cell TransplantationOrganoplatinum CompoundsLymphoma, Non-HodgkinReaction TimeGeneralization, StimulusAntineoplastic Agents, AlkylatingProspective StudiesAnthracyclinesAcoustic StimulationNeoplasm MetastasisDose-Response Relationship, DrugLeukemia, Myeloid, AcuteOvarian NeoplasmsNeoplasm, ResidualCarcinoma, Non-Small-Cell LungRadiotherapy, AdjuvantBone Marrow TransplantationChemotherapy, Cancer, Regional PerfusionClinical Trials as TopicKaplan-Meier EstimateAdenocarcinomaDiscrimination LearningNeutropeniaVisual PerceptionVomitingNeoplasms, Germ Cell and EmbryonalPhysical StimulationRadiotherapyTumor Markers, BiologicalNauseaAntineoplastic Agents, PhytogenicCuesCarmustineAntibiotics, AntineoplasticDiscrimination (Psychology)Brain NeoplasmsMelphalanColorectal NeoplasmsDacarbazineGranulocyte Colony-Stimulating FactorBone NeoplasmsAnalysis of VarianceDisease ProgressionMitoxantroneAttentionDaunorubicinLymphatic MetastasisPattern Recognition, VisualLomustineMagnetic Resonance ImagingPsychophysicsCell Line, TumorInfusions, IntravenousOsteosarcomaGerminomaThiotepaLeukopeniaActuarial AnalysisCamptothecin